Vidarabine

Vidarabine
Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
ATC code	J05AB03 (WHO) S01AD06 (WHO);
Pharmacokinetic data
Protein binding	24-38%
Identifiers
	IUPAC name (2R,3S,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol hydrate;
CAS Number	24356-66-9 ; anhydrous: 5536-17-4 ;
PubChem CID	21704;
IUPHAR/BPS	4806;
DrugBank	D06298 ;
ChemSpider	20400 ;
UNII	FA2DM6879K; anhydrous: 3XQD2MEW34 ;
KEGG	D00406 ;
ChEMBL	ChEMBL1090 ;
NIAID ChemDB	007328;
CompTox Dashboard (EPA)	DTXSID80873976 ;
ECHA InfoCard	100.024.449
Chemical and physical data
Formula	C10H13N5O4
Molar mass	267.245 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N;
	InChI InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7+,10-/m1/s1 ; Key:OIRDTQYFTABQOQ-UHTZMRCNSA-N ;
	(what is this?) (verify)

Vidarabine or 9-β-D-arabinofuranosyladenine (ara-A) is an antiviral drug which is active against herpes simplex and varicella zoster viruses.